Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ARCT
EMBC
Add up to 3 more stocks
ARCT
Arcturus Therapeutics Holdings Inc.
-9.61%
$13.25-1.41Delayed quote: Oct 6, 2026, 2:10 PM EDT
Market Cap
$376.65M
52W Range
$5.50 - $24.17
EMBC
Embecta Corp.
+3.74%
$6.10+0.22Delayed quote: Oct 6, 2026, 2:05 PM EDT
Market Cap
$361.90M
52W Range
$2.77 - $14.91
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 4.12 |
| Forward P/E | N/A | 3.46 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.19 | N/A |
| P/S Ratio | 15.82 | 0.36 |
| P/FCF Ratio | N/A | 2.20 |
| EV/EBITDA | N/A | 5.40 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 95.5% | 59.9% |
| Operating Margin | -111.5% | 24.9% |
| Net Margin | -391.9% | 8.6% |
| ROE | -54.3% | N/A |
| ROA | -41.6% | 6.9% |
| ROIC | -54.1% | 18.0% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 5.88 | 1.68 |
| Quick Ratio | 5.88 | 1.68 |
| Debt/Equity | 0.13 | N/A |
| Interest Coverage | N/A | 3.07 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | 5.4% |
| Payout Ratio | N/A | 21.6% |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.